PubMed Health⌕ Search

PubMed · 8189145

Technological developments in bradycardia pacing. Present and future.

Abstract

Since its invention, there has been a continual increase in bradycardia pacemaker functionality. Although bringing increased benefit to the patient, the modern pacing system has become difficult for many clinicians to understand and evaluate. Therefore, current research is targeted to making the device easier to evaluate, program, and follow up. Currently under investigation are advanced data logging capabilities, intelligent programmer facilities, and automatic functions. The goal is to give the clinician more feedback on how the device and patient are performing, make the system simpler to operate, and make the pacer more responsive to the patient's changing needs. Greater than 80% of the implanted pacers remain at nominal settings for the duration of their operation, presumably because many clinicians are not familiar with the technology or do not have the time to perform follow-up evaluations of the device properly. Thus, making the device simpler to use and more automatic should yield significant patient benefit. Some of the areas in which programmer and implant automaticity are being investigated are in regulating pacer output, sensing, rate response, refractory periods, mode, and upper rate. Such features will provide continuous optimal function, while relieving the clinician of the programming task. Increased data logging will permit long-term analysis of pacemaker and cardiac behavior, which will allow for enhanced pacer follow up and programming, as well as provide clues to unexplained pacer-patient symptoms. In addition, data logging functions will permit the development of advanced automatic features.(ABSTRACT TRUNCATED AT 250 WORDS)

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S E Greenhut. 1993. Technological developments in bradycardia pacing. Present and future.. https://pubmed.ncbi.nlm.nih.gov/8189145/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Sarcoidosis presenting with tachy- and brady-arrhythmias.

We describe a case report of a 49-year-old man admitted to a cardiology unit with a series of arrhythmias with no initially obvious aetiology. Further assessment and the use of cardiac magnetic resonance imaging and histology allowed a diagnosis of cardiac sarcoidosis to be made. Cardiac sarcoidosis is a major cause of death in patients with systemic sarcoidosis. Cardiac magnetic resonance imaging is an additional diagnostic tool for this condition without ionizing radiation exposure.

Bradycardia↗

Non-sinus bradyarrhythmias in very low birth weight infants.

Transient bradycardias occur frequently in preterm infants with apnea of prematurity. However, occurrence of non-sinus bradyarrhythmias in very low birth weight (VLBW) infants has received very little attention. This case series documents transient bradyarrhythmias in VLBW infants. Most frequently observed arrhythmia was a non-sinus atrial rhythm followed by junctional escape rhythm. Ventricular rhythm with wide QRS complexes occurred rarely. The majority of these episodes occurred in the absence of oxygen desaturation. Increase in vagal tone is presumed to mediate this response.

Bradycardia↗

QT interval correction in patients with cirrhosis.

INTRODUCTION: QT interval prolongation is a common electrophysiological abnormality in patients with cirrhosis. As QT interval varies with the heart rate, many QT correction formulas have been proposed, the Bazett's one being the most criticized because it over-corrects the QT interval and may be misleading. This study focused on the QT-RR relationship in patients with cirrhosis to derive a population-specific QT correction formula. METHODS: One hundred cirrhotic patients of different etiology and severity and 53 healthy controls comparable for age and sex were enrolled. The QT-RR relationship was analyzed in patients by five regression analysis models to derive the population-specific QT-RR equation. The QTc was calculated and compared with those calculated by four common QT correction formulas (Bazett, Fridericia, Framingham, and Hodges). The correlation coefficient QTc-RR was calculated as a measure of the independence of QTc from the original RR interval. RESULTS: In patients the QT-RR relationship was best described by the power equation "QT = 453.65 x RR1/3.02" (R2 = 0.41), similar to the Fridericia's formula. Bazett's formula led to the longest QTc (P < 0.0001), which was still significantly influenced by the RR interval (R = -0.39; P < 0.0001), while the estimated equation led to a QTc value not influenced by RR (R = -0.014). CONCLUSION: Bazett's correction should be avoided in patients with cirrhosis because it still provides a rate-dependent QTc value and might be misleading, particularly when assessing the overall preoperative cardiac risk and the effect of drugs affecting the QT interval. In its place, our formula or that of Fridericia can be confidently employed.

Bradycardia↗